Evidence map›Paper›PMID 38559837›Full record

ArticleCurrent health sciences journal

Carcinoembryonic Antigen CEA - Prognostic Value in Immediate Post-Operative Mortality in Colorectal Cancer.

Andreea Firut, Sorin Scurtu, Michael Schenker, Nicoleta Gadea, Ana Maria Patrascu, Vlad Padureanu, Stefan Patrascu, Valeriu Surlin

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current health sciences journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Andreea FirutPhD student, University of Medicine and Pharmacy of Craiova, Romania.
Sorin ScurtuDepartment of Surgery, Clinical Hospital of Filiasi, Romania.
Michael SchenkerDepartment of Oncology, University of Medicine and Pharmacy of Craiova, Romania.
Nicoleta GadeaDepartment of Oncology, University of Medicine and Pharmacy of Craiova, Romania.
Ana Maria PatrascuDepartment of Haematology, University of Medicine and Pharmacy of Craiova, Romania.
Vlad PadureanuDepartment of Internal Medicine, University of Medicine and Pharmacy of Craiova, Romania.
Stefan PatrascuDepartment of Surgery, University of Medicine and Pharmacy of Craiova, Romania.
Valeriu SurlinDepartment of Surgery, University of Medicine and Pharmacy of Craiova, Romania.
University of Medicine and Pharmacy of Craiova · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis study investigates the prognostic significance of carcinoembryonic antigen (CEA) levels in predicting early postoperative mortality in patients who have undergone colorectal cancer surgery.

methodsBetween 2017 and 2022, total of 325 patients were enrolled in the study, and their preoperative serum CEA levels were measured. Relevant clinical and operative data were extracted and correlations between CEA levels and postoperative mortality was analysed.

resultsAmong the surgical cases, 180 patients (55.3%) exhibited elevated CEA levels. Within the early postoperative period of 30 days, 14 patients (4.3%) succumbed, comprising 8 cases (2.4%) of colon cancer and 6 cases (1.8%) of rectal cancer. Notably, only 3 cases (0.9%), consisting of 1 (0.3%) colon cancer and 2 (0.6%) rectal cancer cases, were associated with an elevated CEA level. However, no statistically significant correlations were observed between CEA levels and early postoperative mortality.

conclusionsOur findings indicate that increased CEA levels may not serve as a reliable non-invasive marker for identifying patients at high risk of early mortality in the context of colo-rectal cancer surgery.

Indexed as

carcino-embryogenic antigencolon cancerPostoperative mortality

Identifiers

PMID38559837
PMCPMC10976198
OpenAlexW4394739776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.